SAN DIEGO, July 21, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company with a sole focus of closing the gap in women’s health between promising science and real ...

Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, announces that it will ...

Precision BioSciences, Inc. is a clinical stage gene editing company dedicated to improving life with its novel and proprietary ARCUS ® genome editing platform that differs from other technologies in ...

Cytek Biosciences, Inc. announced that it will release its second quarter 2025 financial results on August 6, 2025, after market close. The company will host a conference call and webcast at 1:30 p.m.

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report second quarter 2025 financial results on Tuesday, August 5, 2025, before ...

Castle Biosciences will announce Q2 2025 financial results on August 4, followed by a conference call at 4:30 PM ET. Castle Biosciences, Inc. will announce its financial results for the second quarter ...

Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2025 Earnings Call Transcript August 14, 2025 Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.45, expectations were $-0.55. Operator: ...

Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Free Report) was the recipient of a large increase in short interest in August. As of August 31st, there was short interest totaling 911,200 shares, an ...